Pancreatic Cancer Research

ResearcherCleveland ClinicActive in the last 2 years

Sricharan Chalikonda

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5049383980. Sources: OpenAlex.

Their work

Papers
9 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
13
Papers, trials and grants by year

2015: 2 papers · 2016: none · 2017: 1 paper · 2018: none · 2019: 1 paper · 2020: none · 2021: 1 paper · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 4 papers

Papers 9

  1. Octogenarians Undergoing Pancreaticoduodenectomy versus Definitive Radiotherapy for Locoregional Therapy of Pancreatic Ductal Adenocarcinoma: A Nationwide Anal… Co-author DOI 10.1245/s10434-026-19109-y↗
  2. ASO Visual Abstract: Octogenarians Undergoing Pancreaticoduodenectomy Versus Definitive Radiotherapy for Locoregional Therapy of Pancreatic Ductal Adenocarcino… Co-author DOI 10.1245/s10434-026-19290-0↗
  3. Adjuvant Radiotherapy After Pancreaticoduodenectomy for Margin-Negative, Node-Positive Pancreatic Ductal Adenocarcinoma: A Nationwide Analysis. Co-author DOI 10.1245/s10434-026-19566-5↗
  4. ASO Visual Abstract: Adjuvant Radiotherapy After Pancreaticoduodenectomy for Margin-Negative, Node-Positive Pancreatic Ductal Adenocarcinoma: A Nationwide Anal… Co-author DOI 10.1245/s10434-026-19655-5↗
  5. Neoadjuvant chemoradiation is associated with decreased lymph node ratio in borderline resectable pancreatic cancer: A propensity score matched analysis. Co-author DOI 10.1016/j.hbpd.2020.08.001↗
  6. Pathologic tumor response to neoadjuvant therapy in borderline resectable pancreatic cancer. Co-author DOI 10.1016/j.hbpd.2019.05.007↗
  7. Diagnostic Laparoscopy Prior to Neoadjuvant Therapy in Pancreatic Cancer Is High Yield: an Analysis of Outcomes and Costs. Last author DOI 10.1007/s11605-017-3470-6↗
  8. Predicting early mortality in resectable pancreatic adenocarcinoma: A cohort study. Co-author DOI 10.1002/cncr.29298↗
  9. Treatment of 200 locally advanced (stage III) pancreatic adenocarcinoma patients with irreversible electroporation: safety and efficacy. Co-author DOI 10.1097/sla.0000000000001441↗

Closest collaborators

The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Muhammad Muntazir Mehdi Khan · 4 shared papers, 2026 · strength 1.38
  2. David L. Bartlett · 4 shared papers, 2026 · strength 1.38
  3. Casey J. Allen · 4 shared papers, 2026 · strength 1.38
  4. Richard Matthew Walsh · 4 shared papers, 2015–2021 · strength 0.38
  5. Gareth J Morris‐Stiff · 4 shared papers, 2015–2021 · strength 0.38
  6. June S. Peng · 3 shared papers, 2017–2021 · strength 0.33
  7. Daniela S. Allende · 1 shared paper, 2019 · strength 0.11
  8. Kevin T. Watkins · 1 shared paper, 2015 · strength 0.05
  9. David Kwon · 1 shared paper, 2015 · strength 0.05
  10. Charles Raben Scoggins · 1 shared paper, 2015 · strength 0.05
  11. Robert C.G. Martin · 1 shared paper, 2015 · strength 0.05
  12. Davendra P. S. Sohal · 1 shared paper, 2015 · strength 0.05
  13. Alok A. Khorana · 1 shared paper, 2015 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.